The science-based economy: The role of health research
Article
It is important we prioritise health research and development, including basic science, public health, behavioural science, and innovation development. The UK’s health sector has clear strengths. It has an enviable academic base, delivers strong return on investment, and is home to an exciting range of businesses with the potential to grow. As we build the role of science in our economy, health research and the life sciences should be a central pillar in our approach.
But we need a strategy to maximise gains. Health research and the life sciences can provide significant value – for our economy, society, and health. However, we will not maximise that value without a coherent strategy. The new 'R&D Roadmap' has begun that process for the research and development as a whole. However, we need to translate that into specific, bold strategies for strength R&D areas – like health and the life sciences.
This report outlines a progressive approach, based on three central pillars.
Related items
Fixing the leak: How to end the £22 billion annual taxpayer losses at the Bank of England
The Bank of England increased its interest rates over recent years, aimed at reducing inflation. But this has also had an unintended effect on the Bank of England’s massive government bond buying – ‘quantitative easing’ – programme.Fairer is faster: The route to greener and healthier domestic transport
The government can speed up efforts to decarbonise transport by targeting the highest emitters.Navigating in the fog: Why the OBR should hold its nerve on the productivity forecast
The fiscal watchdog is under pressure to downgrade its forecast, costing the chancellor billions – but this would be premature.